Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Core groups, antimicrobial resistance and rebound in gonorrhoea in North America.

Chan CH, McCabe CJ, Fisman DN.

Sex Transm Infect. 2012 Apr;88(3):200-4. doi: 10.1136/sextrans-2011-050049. Epub 2011 Dec 14.

PMID:
22169277
2.

The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae.

Lewis DA.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv47-51. doi: 10.1136/sextrans-2013-051020. Review. Erratum in: Sex Transm Infect. 2014 Aug;90(5):400.

PMID:
24243880
3.

Revised simulation model does not predict rebound in gonorrhoea prevalence where core groups are treated in the presence of antimicrobial resistance.

Trecker MA, Hogan DJ, Waldner CL, Dillon JA, Osgood ND.

Sex Transm Infect. 2015 Jun;91(4):300-2. doi: 10.1136/sextrans-2014-051792. Epub 2014 Dec 15.

PMID:
25512669
4.

Public health measures to control the spread of antimicrobial resistance in Neisseria gonorrhoeae in men who have sex with men.

Xiridou M, Soetens LC, Koedijk FD, VAN DER Sande MA, Wallinga J.

Epidemiol Infect. 2015 Jun;143(8):1575-84. doi: 10.1017/S0950268814002519. Epub 2014 Oct 2.

PMID:
25275435
5.

European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe.

Martin IM, Hoffmann S, Ison CA; ESSTI Network.

J Antimicrob Chemother. 2006 Sep;58(3):587-93. Epub 2006 Jul 1.

PMID:
16816397
6.

Current and future treatment options for gonorrhoea.

Ison CA, Deal C, Unemo M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv52-6. doi: 10.1136/sextrans-2012-050913. Epub 2013 Oct 8. Review.

PMID:
24106339
7.

Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993-1998.

Ye S, Su X, Wang Q, Yin Y, Dai X, Sun H.

Sex Transm Dis. 2002 Apr;29(4):242-5.

PMID:
11912467
8.

Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.

Matsumoto T.

Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S35-9. doi: 10.1016/j.ijantimicag.2007.08.029.

PMID:
18164598
9.

Gonococcal antimicrobial resistance: perspectives from the African region.

Ndowa FJ, Francis JM, Machiha A, Faye-Kette H, Fonkoua MC.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv11-5. doi: 10.1136/sextrans-2012-050907. Review.

PMID:
24243873
10.

Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.

Stathi M, Flemetakis A, Miriagou V, Avgerinou H, Kyriakis KP, Maniatis AN, Tzelepi E.

J Antimicrob Chemother. 2006 Apr;57(4):775-9. Epub 2006 Feb 21.

PMID:
16492719
11.

Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.

Knapp JS, Wongba C, Limpakarnjanarat K, Young NL, Parekh MC, Neal SW, Buatiang A, Chitwarakorn A, Mastro TD.

Sex Transm Dis. 1997 Mar;24(3):142-8.

PMID:
9132980
12.

Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.

Heffernan H, Brokenshire M, Woodhouse R, MacCarthy A, Blackmore T.

N Z Med J. 2004 Apr 2;117(1191):U817.

PMID:
15107886
13.

Antimicrobial susceptibility of Neisseria gonorrhoeae in Cuba (1995-1999): implications for treatment of gonorrhea.

Llanes R, Sosa J, Guzmán D, Llop A, Valdés EA, Martínez I, Palma S, Lantero MI.

Sex Transm Dis. 2003 Jan;30(1):10-4.

PMID:
12514435
14.

Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance.

Chen PL, Hsieh YH, Lee HC, Ko NY, Lee NY, Wu CJ, Chang CM, Lee CC, Ko WC.

Int J STD AIDS. 2009 Apr;20(4):225-8. doi: 10.1258/ijsa.2008.008286.

PMID:
19304963
15.

Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?

Lewis DA.

Sex Transm Infect. 2015 Jun;91(4):234-7. doi: 10.1136/sextrans-2014-051731. Epub 2015 Apr 24. Review.

PMID:
25911525
16.

Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.

Dillon JA, Rubabaza JP, Benzaken AS, Sardinha JC, Li H, Bandeira MG, dos Santos Fernando Filho E.

Sex Transm Dis. 2001 Sep;28(9):521-6.

PMID:
11518869
17.

Gonococcal antimicrobial resistance: challenges for public health control.

Ndowa FJ, Ison CA, Cole MJ, Lusti-Narasimhan M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv3-4. doi: 10.1136/sextrans-2013-051395. No abstract available.

PMID:
24243877
18.

Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae.

Stefanelli P.

Expert Rev Anti Infect Ther. 2011 Feb;9(2):237-44. doi: 10.1586/eri.10.171. Review. Retraction in: Expert Rev Anti Infect Ther. 2011 Dec;9(12):1204.

PMID:
21342071
19.

Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.

Chan DJ, Tapsall J.

Int J STD AIDS. 2006 Jun;17(6):410-2.

PMID:
16734965
20.

[Neisseria gonorrhoeae infections].

Furuya R, Tanaka M.

Nihon Rinsho. 2009 Jan;67(1):129-35. Review. Japanese.

PMID:
19177762

Supplemental Content

Support Center